CNTA

Centessa Pharmaceuticals
CNTA

Overview Fund Activity

40 hedge funds and large institutions have $947M invested in Centessa Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 16 closing their positions.

Holders
40
Holders Change
-10
Holders Change %
-20%
% of All Funds
0.7%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
6
Increased
13
Reduced
14
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
GA
1
General Atlantic
New York
$162M
2
RCM
2
RA Capital Management
Massachusetts
$59.7M
3
BBA
3
Baker Bros. Advisors
New York
$18.8M
4
BC
4
Boxer Capital
California
$22.3M
5
CAM
5
Cormorant Asset Management
Massachusetts
$28.7M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$0
2
ACA
2
Avoro Capital Advisors
New York
$0
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$6.06M
4
Millennium Management
4
Millennium Management
New York
$5.63M
5
MIM
5
Monashee Investment Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Two Sigma Investments
51
Two Sigma Investments
New York
– -$222K -9,973 Closed
Geode Capital Management
52
Geode Capital Management
Massachusetts
– -$211K -9,513 Closed
BlackRock
53
BlackRock
New York
– -$110K -4,992 Closed
PCM
54
Pinz Capital Management
New York
– -$20K -900 Closed
1 2
3